Henagliflozin

<!-- Clinical data --> Henagliflozin is a pharmaceutical drug for the treatment of type 2 diabetes. In China, it is approved for adult patients with type 2 diabetes to improve the glycemic control.

Henagliflozin, like other drugs of the gliflozin class, inhibits the transporter protein sodium/glucose cotransporter 2 (SGLT2) which leads to a reduction in blood glucose levels.

In a 26-week placebo-controlled trial of type 2 diabetics, telomere length significantly lengthened, the IGF-1 pathway was inhibited, and immune system function was improved in the henagliflozin group compared to the placebo group. Provided by Wikipedia
Showing 1 - 20 results of 31 for search 'Rui Qin', query time: 0.02s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20